Cointime

Blaze Bioscience

company

About

Blaze Bioscience develops and commercializes products that assist surgeons to treat cancer patients.

  • 1 - 10

Highlights

Total Funding Amount
$16.10M
Funding Rounds
1
Investors
3

Details

Last Funding Type
Series B
Last Funding Money Raised
$16.10M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2010
Number Of Employee
1 - 10
Operating Status
Active

Blaze Bioscience is a Seattle-based, privately-held biotechnology company dedicated to developing products that assist surgeons in their quest to improve the lives of cancer patients. Tumor Paint provides real-time, high-resolution intraoperative visualization of cancer cells, enabling better detection and more complete and precise surgical resection of cancer. The first Tumor Paint product candidate, which is a combination of a targeting peptide and a fluorescent beacon, is under development for multiple solid tumors.

Blaze Bioscience was founded in 2010.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$16.10M
Blaze Bioscience has raised a total of $16.10M in funding over 2 rounds. Their latest funding was raised on Oct 12, 2017 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 12, 2017 Series B $16.10M 3 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
3
Blaze Bioscience is funded by 3 investors. B Cubed Ventures and W&W Capital are the most recent investors.
Investor Name Lead Investor Funding Round
B Cubed Ventures — Series B
W&W Capital — Series B
Keiretsu Forum — Series B
Cointime
เนื้อหา
บริษัท